The IV lidocaine infusion is designed to complement our interventional pain management treatments by delivering a local anesthetic and supportive medications directly into your bloodstream. This therapy includes lidocaine, magnesium, and toradol, selected for their analgesic and anti-inflammatory properties. Used alongside injections, physical therapy, and other treatments, this infusion can add to overall pain relief during recovery.
Key Ingredients
- Lidocaine — A local anesthetic that helps block pain signals, providing targeted discomfort relief
- Magnesium — Supports muscle relaxation, reduces inflammation, and helps ease tension
- Toradol — A powerful anti-inflammatory that offers fast, effective relief from moderate to severe pain
Anti-Inflammatory and Pain-Relief Compounds
The combination of lidocaine, magnesium, and toradol targets pain through complementary routes — lidocaine quiets pain signaling, while toradol (an NSAID) reduces inflammation. The aim is to lower pain perception and support your broader pain management plan.
Complementary Pain Management
The IV lidocaine infusion is used selectively for patients undergoing interventional pain procedures, alongside injections and other treatments during recovery. For some patients, infusions between procedural treatments can add to pain relief, though the effect is often short-lived. Combined with our broader pain management approach, this therapy is one tool we use to help with pain control and quality of life.
Important Considerations
Consult a doctor before use if you have allergies to included ingredients, kidney disease, active gastrointestinal bleeding, are pregnant or breastfeeding, have heart rhythm disorders, or asthma with NSAID sensitivity.
What the evidence shows
There is a real rationale for IV lidocaine in pain care, and it isn’t fringe. An older Cochrane review found that systemic lidocaine and related drugs relieved neuropathic pain better than placebo and about as well as other analgesics in controlled trials (Challapalli et al., 2005). That is the basis on which we use it, in selected patients, for nerve-related pain.
We also think you should hear the other side. A more recent systematic review of IV lidocaine for chronic neuropathic pain found the evidence insufficient and too inconsistent to make a recommendation (Lee et al., 2022), and a randomized study in fibromyalgia found IV lidocaine added to amitriptyline made no meaningful difference (Albertoni Giraldes et al., 2016). Relief, when it comes, is often short-lived. That is why we offer this as a monitored, selective treatment rather than a first-line fix, and why Dr. Movshis reviews whether it fits your situation before any infusion.